Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant <i>Mycoplasma pneumoniae</i>

Abstract

Among Mycoplasma pneumoniae (MP) is one of the major pathogens causing lower respiratory tract infection. Macrolide-resistant Mycoplasma pneumoniae (MRMP) isolates have been increasing and has become a global concern, especially in East Asian countries. This affects the treatment of MP infection; that is, some patients with MRMP infections fever cannot be controlled despite macrolide therapy. Therefore, alternative therapies, including secondary antimicrobials, including tetracyclines, fluoroquinolones, or systemic corticosteroids, were introduced. However, there are insufficient data on these alternative therapies. Thus, this article provides reviews of the recent trends in the epidemiology, diagnosis, and treatment of MRMP.

Keywords

• infection
• macrolide-resistant <i>Mycoplasma pneumoniae</i>
• <i>Mycoplasma pneumoniae</i>
• pediatric